Browse > Article
http://dx.doi.org/10.5851/kosfa.2011.31.6.886

ACE-inhibitory Effect and Physicochemical Characteristics of Yogurt Beverage Fortified with Whey Protein Hydrolysates  

Lim, Sung-Min (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University)
Lee, Na-Kyoung (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University)
Park, Keun-Kyu (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University)
Yoon, Yoh-Chang (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University)
Paik, Hyun-Dong (Division of Animal Life Science and Bio/Molecular Informatics Center, Konkuk University)
Publication Information
Food Science of Animal Resources / v.31, no.6, 2011 , pp. 886-892 More about this Journal
Abstract
This study investigated the ACE-inhibitory effect of yogurt beverage fortified with hydrolysates as well as the suitability of hydrolysates as a nutraceutical additive to yogurt beverage. Three whey protein hydrolysates hydrolyzed by alcalase, protamex, and trypsin were each added to yogurt beverage at concentrations of 1.25, 2.5, and 5 mg/mL. Yogurt beverage fortified with 2.5 mg/mL of hydrolysates had 61-69% ACE-inhibitory activity, whereas yogurt beverage fortified with 5 mg/mL of hydrolysates showed 74% ACE-inhibitory activity. There were no significant differences in ACE-inhibitory activity between the alcalase or protamex hydrolysates during storage; however, trypsin hydrolysate exhibited significant differences. On the other hand, physicochemical characteristics such as pH (3.47-3.77), titratable acidity (0.81-0.84%), colority, viable cell count, and sensory qualities were not significantly different among the tested yogurt beverage samples during storage. These results showed that yogurt beverage fortified with whey protein hydrolysates maintained antihypertensive activity and underwent no unfavorable changes in physicochemical characteristics regardless of enzyme type.
Keywords
angiotensin-converting enzyme; whey protein hydrolysate; yogurt beverage;
Citations & Related Records

Times Cited By Web Of Science : 0  (Related Records In Web of Science)
Times Cited By SCOPUS : 0
연도 인용수 순위
  • Reference
1 Silvia, S. V. and Malcata, F. X. (2005) Caseins as source of bioactive peptides. Int. Dairy J. 15, 1-15.   DOI   ScienceOn
2 Sinha, R., Radha, C., Prakash, J., and Kaul, P. (2007) Whey protein hydrolysate: Functional properties, nutritional quality and utilization in beverage formulation. Food Chem. 101, 1484-1491.   DOI   ScienceOn
3 Van der Ven, C., Grupen, H., Bont, D. B. A., and Voragen, A. G. J. (2002) Optimization of the angiotensin converting enzyme inhibition by whey protein hydrolysates using response surface methodology. Int. Dairy J. 12, 813-820.   DOI   ScienceOn
4 Vermeirssen, V., Van Camp, J., Devos, L., and Verstraete, W. (2003) Release of angiotensin I converting enzyme (ACE) inhibitory activity during in vitro gastrointestinal digestion: From batch experiment to semicontinuous model. J. Agri. Food Chem. 51, 5680-5687.   DOI   ScienceOn
5 FitzGerald, R. J. and Murray, B. A. (2006) Bioactive peptides and lactic fermentations. Int. J. Dairy Technol. 59, 118-125.   DOI   ScienceOn
6 Fuglsang, A., Nilsson, D., and Nyborg, N. C. B. (2002) Cardiovascular effects of fermented milk containing angiotensin-converting enzyme inhibitors evaluated in permanently catheterized, spontaneously hypertensive rats. Appl. Environ. Microbiol. 68, 3566-3569.   DOI
7 Fujita, H., Yamagami, T., and Ohshima, K. (2001) Effects of an ACE inhibitory agent, katsuobushi oligopeptide, in the spontaneously hypertensive rat and in borderline and mildly hypertensive subjects. Nutr. Res. 21, 1149-1158.   DOI   ScienceOn
8 Jang, A. and Lee, M. (2005) Purification and identification of angiotensin converting enzyme inhibitory peptides from beef hydrolysates. Meat Sci. 69, 653-661.   DOI   ScienceOn
9 Kim, S. B., Seo, I. S., Khan, M. A., Ki, K. S., Nam, M. S., and Kim, H. S. (2007) Separation of iron-binding protein from whey through enzymatic hydrolysis. Int. Dairy J. 17, 625-631.   DOI   ScienceOn
10 Korhonen, H. J. T. and Pihlanto, A. (2006) Bioactive peptides: Production and functionality. Int. Dairy J. 16, 945-960.   DOI   ScienceOn
11 Kunji, E. R. S., Mierau, I., Hagting, A., Poolman, B., and Konings, W. N. (1996) The proteolytic systems of lactic acid bacteria. Antonie van Leeuwenhoek 70, 187-221.   DOI
12 Lopez-Fandino, R., Otte J., and van Camp, J. (2006) Physiological, chemical and technological aspects of milk-proteinderived peptides with antihypertensive and ACE-inhibitory activity. Int. Dairy J. 16, 1277-1293.   DOI   ScienceOn
13 Minervini, F., Algaron, F., Rizzello, C. G., Fox, P. F., Monnet, V., and Gobbetti, M. (2003) Angiotensin I-converting-enzyme-inhibitory and antibacterial peptides from Lactobacillus helveticus PR4 proteinase-hydrolyzed caseins of milk from six species. Appl. Environ. Microbiol. 69, 5297-5305.   DOI
14 Christensen, J. E., Dudley, E. G., Pederson, J. A., and Steele, J. L. (1999) Peptidases and amino acid catabolism in lactic acid bacteria. Antonie van Leeuwenhoek 76, 217-246.   DOI   ScienceOn
15 AOAC (1995) Official methods of analysis. 16th ed, Association of Official Analytical Chemists, Washington, DC, USA.
16 Ariyoshi, Y. (1993) Angiotensin-converting enzyme inhibitor derived from food protein. Trends Food Sci. Technol. 4, 139-144.   DOI   ScienceOn
17 Campbell, D. J. (2003) The renin-angiotensin and the kallikrein-kinin systems. Int. J. Biochem. Cell Biotechnol. 35, 784-791.   DOI   ScienceOn
18 Clare, A. and Swaisgood, H. E. (2000) Bioactive milk peptides: a prospectus. J. Dairy Sci. 86, 1187-1195.
19 Cushman, D. W. and Cheung, H. S. (1971) Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharmacol. 20, 1637-1648.   DOI   ScienceOn
20 Donkor, O. N., Henriksson, A., Vasiljevic, T., and Shah, N. P. (2007) Proteolytic activity of dairy lactic acid bacteria and probiotics as determinant of viability and in vitro angiotensin-converting enzyme inhibitory activity in fermented milk. Lait 87, 21-38.   DOI
21 Pihlanto-Leppala, A., Koskinen, P., Piilola, K., Tupasela, T., and Korhonen, H. (2000) Angiotensin I-converting enzyme inhibitory properties of whey protein digests: Concentration and characterization of active peptides. J. Dairy Res. 67, 53-64.   DOI   ScienceOn
22 Yamamoto, N. (1997) Antihypertensive peptides derived from food proteins. Biopolymers 43, 129-134.   DOI   ScienceOn
23 Yamamoto, N., Akino, A., and Takano, T. (1994) Antihypertensive effect of the peptides derived from casein by an extracellular proteinase from Lactobacillus helveticus CP790. J. Dairy Sci. 77, 917-922.   DOI
24 Yusuf, S., Lonn, E., Bosch, J., and Gerstein, H. (1999) Summary of randomised trials of angiotensin converting enzyme inhibitors. Clin. Exp. Hypertens. 21, 835-845.   DOI
25 Nicholas, J. A. and Eric, C. R. (1996) Characterization of casein phosphopeptides prepared using alcalase. Enzyme Microb. Technol. 19, 202-207.   DOI   ScienceOn
26 Otte, J., Qvist, K. B., Pedersen, M., Vogensen, F. K., and Flambard, B. (2003) ACE-inhibitory activity of fermented milks: Effects of culture and protein concentration. Poster at the Conference Milk Proteins: Quality and Health Aspects., Wadahl, Norway, pp. 13-16.
27 SAS (1999) SAS/STAT Software for PC. SAS Institute Inc., Cary, NC, USA.
28 Seppo, L., Jauhiainen, T., Poussa, T., and Korpela, R. (2003) A fermented milk high in bioactive peptides has a blood pressure-lowering effect in hypertensive subjects. Am. J. Clin. Nutr. 77, 326-330.
29 Shah, N. P. (2000) Effect of milk-derived bioactives: An overview. Br. J. Nutr. 84, S3-S10.